Latanoprost API: Powering Glaucoma Treatment Through Advanced Pharmaceutical Manufacturing
The Latanoprost API Market was valued at USD 1,050.9 million in 2025 and is projected to grow to USD 1,500 million by 2035, registering a CAGR of 3.6% during the forecast period. This steady growth trajectory reflects the essential role of latanoprost active pharmaceutical ingredients in addressing the demand for effective glaucoma treatments, improved patient outcomes, and innovative...
0 Comentários 0 Compartilhamentos 8 Visualizações 0 Anterior